World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Emma Akuffo, BSc, PhD

Emma oversees the Study Management, Advanced Research Science and Quality Assurance teams at Richmond Pharmacology.

During her 10 years at Richmond Pharmacology, Emma has worked on over 100 Early Phase Studies ensuring optimal delivery of clinical trial outcomes for our sponsors. This has been achieved through efficient, streamlined processes, the production of high quality documentation and stringent regulatory compliance.

Prior to working at Richmond Pharmacology, Emma worked on various drug development projects within the biotechnology and pharmaceutical industry as well as academia.

Emma is a full member of the British Pharmacological Society and holds a BSc in Biology & Chemistry, PhD in Biochemistry and Postgraduate Certificate in Business Administration.

Back to experts

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more